Association between hepatocyte growth factor gene polymorphism and essential hypertension

Hypertension Research

Volumn 27, Issue 4, 2004, Pages 247-251

  Motone, Masaharu ^a   Katsuya, Tomohiro ^a   Ishikawa, Kazuhiko ^a   Iwashima, Yoshio ^a   Sugimoto, Ken ^a   Yamamoto, Koichi ^a   Fu, Yuxiao ^a   Matsuo, Akiko ^a   Ohishi, Mitsuru ^a   Rakugi, Hiromi ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Essential hypertension; Genetics; Hepatocyte growth factor; Single nucleotide polymorphism; TaqMan polymerase chain reaction

Indexed keywords

ADENINE; CYTOSINE; GROWTH FACTOR; SCATTER FACTOR;

ADULT; AGED; ALLELE; ARTICLE; BLOOD PRESSURE REGULATION; CELL PROTECTION; CELL REGENERATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; FEMALE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTRON; JAPAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; OBESITY; ORGAN INJURY; OUTPATIENT; POLYMERASE CHAIN REACTION; PREDICTION; PREVALENCE; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; UNIVERSITY HOSPITAL; VASCULAR ENDOTHELIUM;

AGED; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATOCYTE GROWTH FACTOR; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; SEX DISTRIBUTION;

EID: 2342464192     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.27.247     Document Type: Article

References (30)

1. Cohn JN, Finkelstein SM: Abnormalities of vascular compliance in hypertension, aging and heart failure. J Hypertens 1992; 10(Suppl): S61-S64.
2. Lockette W, Otsuka Y, Carretero O: The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 1986;8:II61-II66.
3. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27.
4. Hamanoue M, Kawaida K, Takao S, et al: Rapid and marked induction of hepatocyte growth factor during liver regeneration after ischemic or crush injury. Hepatology 1992; 16: 1485-1492.
5. Nagaike M, Hirao S, Tajima H, et al: Renotropic functions of hepatocyte growth factor in renal regeneration after unilateral nephrectomy. J Biol Chem 1991; 266: 22781-22784.
6. Igawa T, Matsumoto K, Kanda S, Saito Y, Nakamura T: Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 1993; 265: F61-1769.
7. Nishimura M, Nakano K, Ushiyama M, et al: Increased serum concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy. J Clin Endocrinol Metab 1998; 83: 195-198.
8. Shinoda K, Ishida S, Kawashima S, et al: Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy. Curr Eye Res 2000; 21: 655-661.
9. Szprynger K, Szczepanska M, Dyduch A: Hepatocyte growth factor in kidney diseases. Przegl Lek 2000; 57: 757-760.
10. Nakamura S, Moriguchi A, Morishita R, et al: A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension. Biochem Biophys Res Commun 1998; 242: 238-243.
11. Nakamura Y, Morishita R, Nakamura S, et al: A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension 1996; 28: 409-413.
12. Morishita R, Moriguchi A, Higaki J, Ogihara T: Hepatocyte growth factor (HGF) as a potential index of severity of hypertension. Hypertens Res 1999; 22: 161-167.
13. Yamamoto Y, Kohara K, Tabara Y, Miki T: Association between carotid arterial remodeling and plasma concentration of circulating hepatocyte growth factor. J Hypertens 2001; 19: 1975-1979.
14. Yamamoto Y, Kohara K, Tabara Y, Igase M, Nakura J, Miki T: Plasma hepatocyte growth factor and the relationship between risk factors and carotid atherosclerosis. Hypertens Res 2002; 25: 661-667.
15. Morishita R, Aoki M, Yo Y, Ogihara T: Hepatocyte growth factor as cardiovascular hormone: role of HGF in the pathogenesis of cardiovascular disease. Endocr J 2002; 49: 273-284.
16. Hayashi Y, Saitoh S, Takagi S, Tuchihashi K, Miura T, Shimamoto K: Hepatocyte growth factor and 24-hour ambulatory blood pressure monitoring. Hypertens Res 2002; 25: 655-660.
17. Komai N, Ohishi M, Morishita R, et al: Serum hepatocyte growth factor concentration is correlated with the forearm vasodilator response in hypertensive patients. Am J Hypertens 2002; 15: 499-506.
18. Nakamura T: Structure and function of hepatocyte growth factor. Prog Growth Factor Res 1991; 3: 67-85.
19. Boros P, Miller CM: Hepatocyte growth factor: a multi-functional cytokine. Lancet 1995; 345: 293-295.
20. Nakamura Y, Morishita R, Higaki J, et al: Expression of local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun 1995; 215: 483-488.
21. Morishita R, Nakamura S, Hayashi S, et al: Contribution of a vascular modulator, hepatocyte growth factor (HGF), to the pathogenesis of cardiovascular disease. J Atheroscler Thromb 1998; 4: 128-134.
22. Morishita R, Aoki M, Nakamura S, et al: Potential role of a novel vascular modulator, hepatocyte growth factor (HGF), in cardiovascular disease: characterization and regulation of local HGF system. J Atheroscler Thromb 1997; 4: 12-19.
23. Matsumoto K, Tajima H, Okazaki H, Nakamura T: Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-beta 1 and glucocorticoids. J Biol Chem 1992; 267: 24917-24920.
24. Okajima A, Miyazawa K, Kitamura N: Characterization of the promoter region of the rat hepatocyte-growth-factor/scatter-factor gene. Eur J Biochem 1993; 213: 113-119.
25. Liu Y, Michalopoulos GK, Zarnegar R: Structural and functional characterization of the mouse hepatocyte growth factor gene promoter. J Biol Chem 1994; 269: 4152-4160.
26. Gohda E, Matsunaga T, Kataoka H, Yamamoto I: TGF-beta is a potent inhibitor of hepatocyte growth factor secretion by human fibroblasts. Cell Biol Int Rep 1992; 16: 917-926.
27. Nakamura Y, Morishita R, Higaki J, et al: Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J Hypertens 1996; 14: 1067-1072.
28. Onimaru M, Yonemitsu Y, Tanii M, et al: Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs. Circ Res 2002; 91: 923-930.
29. Haug C, Schmid-Kotsas A, Zorn U, et al: Hepatocyte growth factor is upregulated by low-density lipoproteins and inhibits endothelin-1 release. Am J Physiol Heart Circ Physiol 2000; 279: H2865-H2871.
30. 2+ - and phosphoinositide 3-kinase/Akt-dependent phosphorylation in aortic endothelial cells. Biochem J 2003; 374: 63-69.